CEL-SCI Corporation (CVM)
USD 0.2
(-6.42%)
USD 0.2
(-6.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 9.42 Million USD | 227.92% |
| 2022 | -7.36 Million USD | 63.32% |
| 2021 | -20.08 Million USD | -1178.38% |
| 2020 | -1.57 Million USD | -131.03% |
| 2019 | 5.06 Million USD | 64.94% |
| 2018 | 3.06 Million USD | -74.06% |
| 2017 | 11.83 Million USD | 17.28% |
| 2016 | 10.09 Million USD | 325.87% |
| 2015 | -4.46 Million USD | 39.55% |
| 2014 | -7.39 Million USD | -777.19% |
| 2013 | 1.09 Million USD | 138.42% |
| 2012 | -2.84 Million USD | -484.75% |
| 2011 | 738.4 Thousand USD | 102.9% |
| 2010 | -25.46 Million USD | 21.55% |
| 2009 | -32.46 Million USD | -6249.08% |
| 2008 | -511.25 Thousand USD | 95.35% |
| 2007 | -10.99 Million USD | -36.05% |
| 2006 | -8.08 Million USD | -313.4% |
| 2005 | -1.95 Million USD | 54.16% |
| 2004 | -4.26 Million USD | -384.49% |
| 2003 | -880.01 Thousand USD | -188.56% |
| 2002 | -304.97 Thousand USD | 82.6% |
| 2001 | -1.75 Million USD | 74.54% |
| 2000 | -6.88 Million USD | -154.98% |
| 1999 | -2.7 Million USD | 3.57% |
| 1998 | -2.8 Million USD | 20.0% |
| 1997 | -3.5 Million USD | 0.0% |
| 1996 | -3.5 Million USD | -12.9% |
| 1995 | -3.1 Million USD | -14.81% |
| 1994 | -2.7 Million USD | -22.73% |
| 1993 | -2.2 Million USD | 31.25% |
| 1992 | -3.2 Million USD | -3100.0% |
| 1991 | -100 Thousand USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | -100.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 11.74 Million USD | 60.44% |
| 2024 Q2 | 7.32 Million USD | -25.72% |
| 2024 Q1 | 9.85 Million USD | 4.58% |
| 2023 Q3 | 8.88 Million USD | 101.31% |
| 2023 Q1 | -3.12 Million USD | 57.56% |
| 2023 Q2 | 4.41 Million USD | 241.14% |
| 2023 FY | 9.42 Million USD | 227.92% |
| 2023 Q4 | 9.42 Million USD | 6.08% |
| 2022 Q1 | -21.48 Million USD | -6.95% |
| 2022 Q4 | -7.36 Million USD | 40.47% |
| 2022 Q3 | -12.37 Million USD | 32.12% |
| 2022 Q2 | -18.23 Million USD | 15.11% |
| 2022 FY | -7.36 Million USD | 63.32% |
| 2021 Q4 | -20.08 Million USD | 2.95% |
| 2021 Q3 | -20.69 Million USD | -403.2% |
| 2021 Q2 | 6.82 Million USD | 183.6% |
| 2021 Q1 | -8.16 Million USD | -419.67% |
| 2021 FY | -20.08 Million USD | -1178.38% |
| 2020 Q3 | -5.97 Million USD | -1843.67% |
| 2020 FY | -1.57 Million USD | -131.03% |
| 2020 Q1 | 4.86 Million USD | -3.84% |
| 2020 Q2 | -307.63 Thousand USD | -106.32% |
| 2020 Q4 | -1.57 Million USD | 73.72% |
| 2019 Q2 | 7.93 Million USD | 17.8% |
| 2019 FY | 5.06 Million USD | 64.94% |
| 2019 Q4 | 5.06 Million USD | 26.9% |
| 2019 Q3 | 3.99 Million USD | -49.68% |
| 2019 Q1 | 6.73 Million USD | 119.29% |
| 2018 Q1 | 11.98 Million USD | 1.27% |
| 2018 FY | 3.06 Million USD | -74.06% |
| 2018 Q4 | 3.06 Million USD | -72.07% |
| 2018 Q3 | 10.99 Million USD | -3.68% |
| 2018 Q2 | 11.4 Million USD | -4.82% |
| 2017 Q2 | 11.58 Million USD | 8.5% |
| 2017 FY | 11.83 Million USD | 17.28% |
| 2017 Q4 | 11.83 Million USD | 1405.5% |
| 2017 Q3 | -906.68 Thousand USD | -107.83% |
| 2017 Q1 | 10.67 Million USD | 467.41% |
| 2016 FY | 10.09 Million USD | 325.87% |
| 2016 Q1 | -9.31 Million USD | -108.38% |
| 2016 Q2 | -6.04 Million USD | 35.05% |
| 2016 Q3 | -5.21 Million USD | 13.74% |
| 2016 Q4 | -2.9 Million USD | 44.31% |
| 2015 Q2 | -1.49 Million USD | 82.05% |
| 2015 Q4 | -4.46 Million USD | 55.09% |
| 2015 Q3 | -9.94 Million USD | -564.63% |
| 2015 Q1 | -8.34 Million USD | -12.85% |
| 2015 FY | -4.46 Million USD | 39.55% |
| 2014 Q1 | -12.35 Million USD | -1231.76% |
| 2014 Q2 | -9.47 Million USD | 23.26% |
| 2014 FY | -7.39 Million USD | -777.19% |
| 2014 Q4 | -7.39 Million USD | 43.84% |
| 2014 Q3 | -13.16 Million USD | -38.84% |
| 2013 Q1 | -9.59 Million USD | -237.83% |
| 2013 Q4 | 1.09 Million USD | 146.47% |
| 2013 Q3 | -2.34 Million USD | 59.84% |
| 2013 Q2 | -5.84 Million USD | 39.06% |
| 2013 FY | 1.09 Million USD | 138.42% |
| 2012 Q4 | -2.84 Million USD | 53.59% |
| 2012 Q2 | -4.16 Million USD | -721.8% |
| 2012 Q1 | -507.22 Thousand USD | -168.69% |
| 2012 FY | -2.84 Million USD | -484.75% |
| 2012 Q3 | -6.12 Million USD | -46.87% |
| 2011 FY | 738.4 Thousand USD | 102.9% |
| 2011 Q4 | 738.4 Thousand USD | 113.08% |
| 2011 Q3 | -5.64 Million USD | 66.06% |
| 2011 Q2 | -16.63 Million USD | 15.78% |
| 2011 Q1 | -19.75 Million USD | 22.43% |
| 2010 Q3 | -29.37 Million USD | 10.75% |
| 2010 Q4 | -25.46 Million USD | 13.3% |
| 2010 FY | -25.46 Million USD | 21.55% |
| 2010 Q2 | -32.9 Million USD | 5.81% |
| 2010 Q1 | -34.93 Million USD | -7.63% |
| 2009 Q3 | -4.51 Million USD | -5260.13% |
| 2009 Q1 | 1053.00 USD | 100.21% |
| 2009 Q2 | -84.16 Thousand USD | -8092.97% |
| 2009 Q4 | -32.46 Million USD | -619.51% |
| 2009 FY | -32.46 Million USD | -6249.08% |
| 2008 Q1 | -9.33 Million USD | 15.04% |
| 2008 Q2 | 391.52 Thousand USD | 104.19% |
| 2008 Q3 | -3.16 Million USD | -907.47% |
| 2008 Q4 | -511.25 Thousand USD | 83.83% |
| 2008 FY | -511.25 Thousand USD | 95.35% |
| 2007 Q1 | -7.17 Million USD | 11.18% |
| 2007 Q2 | -5.86 Million USD | 18.21% |
| 2007 FY | -10.99 Million USD | -36.05% |
| 2007 Q4 | -10.99 Million USD | 43.49% |
| 2007 Q3 | -19.45 Million USD | -231.41% |
| 2006 FY | -8.08 Million USD | -313.4% |
| 2006 Q2 | -1.73 Million USD | 7.99% |
| 2006 Q4 | -8.08 Million USD | -493.73% |
| 2006 Q3 | -1.36 Million USD | 21.5% |
| 2006 Q1 | -1.88 Million USD | 3.6% |
| 2005 Q2 | -2.17 Million USD | 33.94% |
| 2005 Q4 | -1.95 Million USD | -31.3% |
| 2005 FY | -1.95 Million USD | 54.16% |
| 2005 Q1 | -3.29 Million USD | 22.83% |
| 2005 Q3 | -1.48 Million USD | 31.5% |
| 2004 Q3 | -5.36 Million USD | -178.75% |
| 2004 Q4 | -4.26 Million USD | 20.53% |
| 2004 FY | -4.26 Million USD | -384.49% |
| 2004 Q2 | -1.92 Million USD | 21.41% |
| 2004 Q1 | -2.44 Million USD | -178.3% |
| 2003 Q2 | -419.12 Thousand USD | 25.88% |
| 2003 Q1 | -565.48 Thousand USD | -85.42% |
| 2003 FY | -880.01 Thousand USD | -188.56% |
| 2003 Q4 | -880.01 Thousand USD | -15.19% |
| 2003 Q3 | -763.98 Thousand USD | -82.28% |
| 2002 Q3 | -663.09 Thousand USD | 39.07% |
| 2002 Q1 | -1.47 Million USD | 15.81% |
| 2002 Q4 | -304.97 Thousand USD | 54.01% |
| 2002 Q2 | -1.08 Million USD | 26.24% |
| 2002 FY | -304.97 Thousand USD | 82.6% |
| 2001 Q1 | -3.68 Million USD | 46.43% |
| 2001 Q4 | -1.75 Million USD | 32.38% |
| 2001 Q3 | -2.59 Million USD | -22.21% |
| 2001 FY | -1.75 Million USD | 74.54% |
| 2001 Q2 | -2.12 Million USD | 42.49% |
| 2000 Q4 | -6.88 Million USD | 27.41% |
| 2000 Q1 | -4.6 Million USD | -70.37% |
| 2000 Q3 | -9.48 Million USD | 20.82% |
| 2000 FY | -6.88 Million USD | -154.98% |
| 2000 Q2 | -11.97 Million USD | -160.39% |
| 1999 Q4 | -2.7 Million USD | -8.0% |
| 1999 Q3 | -2.5 Million USD | 7.41% |
| 1999 Q2 | -2.7 Million USD | -8.0% |
| 1999 FY | -2.7 Million USD | 3.57% |
| 1999 Q1 | -2.5 Million USD | 10.71% |
| 1998 FY | -2.8 Million USD | 20.0% |
| 1998 Q4 | -2.8 Million USD | -12.0% |
| 1998 Q3 | -2.5 Million USD | 16.67% |
| 1998 Q2 | -3 Million USD | 69.39% |
| 1998 Q1 | -9.8 Million USD | -180.0% |
| 1997 Q3 | -3.4 Million USD | 8.11% |
| 1997 Q1 | -5 Million USD | -42.86% |
| 1997 FY | -3.5 Million USD | 0.0% |
| 1997 Q4 | -3.5 Million USD | -2.94% |
| 1997 Q2 | -3.7 Million USD | 26.0% |
| 1996 FY | -3.5 Million USD | -12.9% |
| 1996 Q2 | -3.2 Million USD | -39.13% |
| 1996 Q3 | -5.6 Million USD | -75.0% |
| 1996 Q4 | -3.5 Million USD | 37.5% |
| 1996 Q1 | -2.3 Million USD | 25.81% |
| 1995 FY | -3.1 Million USD | -14.81% |
| 1995 Q3 | -2.9 Million USD | -61.11% |
| 1995 Q1 | -2 Million USD | 25.93% |
| 1995 Q2 | -1.8 Million USD | 10.0% |
| 1995 Q4 | -3.1 Million USD | -6.9% |
| 1994 FY | -2.7 Million USD | -22.73% |
| 1994 Q4 | -2.7 Million USD | -3.85% |
| 1994 Q3 | -2.6 Million USD | -18.18% |
| 1994 Q2 | -2.2 Million USD | -4.76% |
| 1994 Q1 | -2.1 Million USD | 4.55% |
| 1993 Q3 | -2.4 Million USD | -50.0% |
| 1993 Q4 | -2.2 Million USD | 8.33% |
| 1993 FY | -2.2 Million USD | 31.25% |
| 1993 Q1 | -1.1 Million USD | 65.63% |
| 1993 Q2 | -1.6 Million USD | -45.45% |
| 1992 Q1 | -500 Thousand USD | -400.0% |
| 1992 Q2 | -14 Million USD | -2700.0% |
| 1992 Q3 | -13.7 Million USD | 2.14% |
| 1992 Q4 | -3.2 Million USD | 76.64% |
| 1992 FY | -3.2 Million USD | -3100.0% |
| 1991 FY | -100 Thousand USD | 0.0% |
| 1991 Q4 | -100 Thousand USD | 66.67% |
| 1991 Q2 | -500 Thousand USD | -25.0% |
| 1991 Q3 | -300 Thousand USD | 40.0% |
| 1991 Q1 | -400 Thousand USD | 0.0% |
| 1990 Q2 | -300 Thousand USD | 0.0% |
| 1990 Q4 | - USD | 100.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q1 | -300 Thousand USD | 0.0% |
| 1990 Q3 | -500 Thousand USD | -66.67% |
| 1989 Q3 | -100 Thousand USD | 0.0% |
| 1989 Q4 | - USD | 100.0% |
| 1989 FY | - USD | -100.0% |
| 1989 Q1 | -100 Thousand USD | -200.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -4.94 Million USD | 290.656% |
| Ampio Pharmaceuticals, Inc. | -3.81 Million USD | 347.078% |
| Armata Pharmaceuticals, Inc. | 106.84 Million USD | 91.178% |
| Actinium Pharmaceuticals, Inc. | -74.56 Million USD | 112.642% |
| Azitra, Inc. | -910.04 Thousand USD | 1135.778% |
| Can-Fite BioPharma Ltd. | -4.23 Million USD | 322.417% |
| Chromocell Therapeutics Corporation | 1.17 Million USD | -704.066% |
| Calidi Biotherapeutics, Inc. | 5.18 Million USD | -81.724% |
| iBio, Inc. | -9.75 Million USD | 196.677% |
| Lineage Cell Therapeutics, Inc. | -32.49 Million USD | 129.012% |
| MAIA Biotechnology, Inc. | -7.15 Million USD | 231.82% |
| Matinas BioPharma Holdings, Inc. | -1.28 Million USD | 835.832% |
| Navidea Biopharmaceuticals, Inc. | 438.44 Thousand USD | -2049.879% |
| NovaBay Pharmaceuticals, Inc. | -390 Thousand USD | 2516.927% |
| NanoViricides, Inc. | -4.79 Million USD | 296.466% |
| Oragenics, Inc. | -3.17 Million USD | 397.276% |
| BiomX Inc. | -772 Thousand USD | 1320.986% |
| BiomX Inc. | -772 Thousand USD | 1320.986% |
| Protalix BioTherapeutics, Inc. | 2.64 Million USD | -256.102% |
| Palatin Technologies, Inc. | -8.93 Million USD | 205.471% |
| Scorpius Holdings, Inc. | 13.85 Million USD | 31.977% |
| Theriva Biologics, Inc. | -21.02 Million USD | 144.837% |